Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Press releaseGlobeNewswire· May 26, 2026

Groupe DÉKUPLE : activité du 1er trimestre 2026

View original at globenewswire.com
Groupe DÉKUPLE : activité du 1er trimestre 2026 ACTIVITÉ DU 1ER TRIMESTRE 2026 _____ Chiffre d’affaires : 61,2 M€ (+5,0 %) Revenu net : 45,3 M€ (+2,4 %)Croissance portée par le Marketing Digital (+8,2 %) et l’International (+50,0 %) Paris, le 26 mai 2026 (8h00) - Le Groupe DÉKUPLE, leader européen de la Communication e…
Opening lines of the source · GlobeNewswire · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The international share of net revenue represents 14.6% in Q1 2026, versus 9.9% one year earlier, confirming the continuation of the Group's geographic expansion.

    60% confidence
  • The Group remains attentive to external growth opportunities in line with its ambition of European leadership in communication and data marketing.

    60% confidence
  • Strong international growth reflects a scale change, with durable reinforcement of European presence and capacity to support clients in key markets.

    60% confidence
  • The Group continues to reinforce synergies between its entities, an essential lever of operational efficiency and value creation, as well as optimize Magazines and Insurance activities, concentrating investments on the most profitable segments and recurring revenue-generating models.

    60% confidence
  • Digital Marketing and Digital transformation growth is at the heart of the Group's model, supported by expertise development in data, artificial intelligence, and marketing technologies.

    60% confidence
  • After a start of year marked by wait-and-see behavior, particularly in France, there is a progressive improvement in commercial dynamics, especially in consulting and agencies/solutions activities.

    60% confidence
  • Advertisers remain selective but continue to invest in the most strategic performance-creating levers.

    60% confidence
  • Groupe DÉKUPLE approaches coming quarters with confidence in an environment that remains mixed, particularly in France.

    60% confidence
  • Q1 2026 confirms the resilience of the Group's model in a still-mixed environment. The progress, driven by Digital Marketing and strong international acceleration, illustrates the solidity of fundamentals and the relevance of positioning.

    60% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com